Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
XENE
#1352
Xenon Pharmaceuticals Inc
43.230
0
-2.43%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-2.43%
Monthly Change
+1.98%
6 month change
+5.98%
Cambio anual
+5.98%
Cierres anteriores
44.305
0
Open
43.250
0
Bid
Ask
Low
43.230
0
High
43.250
0
Volumen
189
Markets
Acciones
Atención Sanitaria
XENE
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
35.81 M
51.92 M
63.04 M
75.43 M
76.54 M
83.19 M
—
Valuation ratios
Enterprise value
513.47 M
1.45 B
2.29 B
3.24 B
2.86 B
3.53 B
11.26 B
Price to earnings ratio
—
—
-18.09
-16.45
-13.02
-10.28
-39.89
Price to sales ratio
—
—
239.11
15.1 K
2 869.8
—
—
Price to cash flow ratio
—
—
-22.92
-20.67
-16.83
12.73
-23.87
Price to book ratio
—
—
3.13
3.24
4.04
6.11
8.99
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.15
0.14
0.17
0.19
0.29
0.55
0.53
Return on equity %
0.17
0.14
0.17
0.2
0.31
0.59
0.57
Return on invested capital %
509.62
2 537.53
614.65
359.58
452.44
1 248.8
1 065.43
Gross margin %
100
100
100
100
100
100
—
Operating margin %
97.31
428.45
1 368.91
107.56 K
26.25 K
4 974.27
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
89.65
427.85
1 328.95
91.65 K
22.02 K
4 612.13
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.3
39.03
26.44
23.65
17.85
13.42
58.73
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.19
0.05
0.01
0
0
0.01
0.01
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.06
—
—
—
—
—
—
Long term debt to total equity ratio
0.06
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
1.63
2.17
2.33
3.52
3.53
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
14.35
9.75
8.05
6.93
25.92
Net current asset value per share
—
—
9.92
9.64
8.16
7.07
26.66
Tangible book value per share
—
—
11.92
13.87
9.69
7.34
31.38
Working capital per share
—
—
9.54
9.23
7.7
6.55
24.82
Book value per share
—
—
11.92
13.87
9.69
7.34
31.38
Noticias
Las acciones de Xenon Pharmaceuticals alcanzan un máximo de 52 semanas en 46,68 dólares
Acciones de Xenon Pharmaceuticals alcanzan un máximo de 52 semanas en $46.68
Xenon Pharmaceuticals stock hits 52-week high at $46.68
Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus
Los resultados de Xenon se acercan mientras los inversores se preparan para el catalizador de Fase 3
Xenon earnings loom as investors brace for Phase 3 catalyst
Wolfe Research inicia cobertura de Xenon Pharmaceuticals con calificación de superar al mercado
Wolfe Research initiates Xenon Pharmaceuticals stock coverage with outperform rating
Xenon Pharmaceuticals Stock Scores RS Rating Upgrade
Stifel eleva el precio objetivo de Xenon Pharmaceuticals a 66 dólares por el potencial de XEN1101
Stifel eleva precio objetivo de Xenon Pharmaceuticals a $66 por potencial de XEN1101
Stifel raises Xenon Pharmaceuticals stock price target to $66 on XEN1101 potential